| DIRECT COMPETITOR COMPARISON | |
| ISTA | ACL | AGN | Pvt1 | Industry | | Market Cap: | 140.11M | 44.28B | 17.72B | N/A | 161.24M | | Employees: | 225 | 15,400 | 8,300 | 13,0001 | 103 | | Qtrly Rev Growth (yoy): | 47.60% | 5.90% | 3.90% | N/A | 20.50% | | Revenue (ttm): | 104.48M | 6.28B | 4.34B | 2.50B1 | 46.74M | | Gross Margin (ttm): | 75.28% | 76.53% | 83.19% | N/A | 68.58% | | EBITDA (ttm): | 3.46M | 2.51B | 1.13B | N/A | -7.12M | | Oper Margins (ttm): | 2.29% | 36.65% | 22.19% | N/A | 2.25% | | Net Income (ttm): | -55.07M | 1.97B | 561.90M | N/A | N/A | | EPS (ttm): | -1.660 | 6.558 | 1.842 | N/A | -0.17 | | P/E (ttm): | N/A | 22.58 | 31.64 | N/A | 17.12 | | PEG (5 yr expected): | N/A | 1.72 | 1.63 | N/A | 1.04 | | P/S (ttm): | 1.38 | 7.10 | 4.16 | N/A | 4.17 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.50 | -1.02% | 57.19B | 12.32 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 46.92 | -1.12% | 13.57B | 15.70 | | Genzyme Corp. | GENZ | 51.07 | -0.87% | 13.55B | 29.12 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.56 | -0.89% | 41.90B | 18.00 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.95 | -1.85% | 8.91B | 1019.39 | | Teva Pharmaceutical Industries Limited | TEVA | 52.88 | -0.53% | 46.59B | 48.38 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 36.96 | -2.25% | 3.92B | 19.05 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.95 | -1.08% | 2.97B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.01 | -1.53% | 5.50B | 110.49 | | Pfizer Inc. | PFE | 18.25 | -1.83% | 147.27B | 15.16 | | Johnson & Johnson | JNJ | 62.89 | -0.65% | 173.52B | 13.73 | | GlaxoSmithKline plc | GSK | 42.26 | -1.45% | 107.13B | 13.42 | | Sanofi-Aventis | SNY | 38.43 | -2.61% | 100.35B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.38 | -0.84% | 125.78B | 16.58 | | RHHBY.PK | 41.46 | -1.96% | N/A | N/A | | AstraZeneca plc | AZN | 45.29 | -2.35% | 65.67B | 9.09 | | Abbott Laboratories | ABT | 54.08 | -0.61% | 83.65B | 14.65 | | Bristol-Myers Squibb Co. | BMY | 25.38 | -1.05% | 50.28B | 13.13 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | ACL | | 8 HealthCare Stocks With 3%+ Dividends
Sun 12:52am -
at Seeking Alpha | | • | ACL | | The World's Best Dividend Stocks
Wed, Nov 25 -
at Motley Fool | | • | ACL | | Paragon Innovations plans Richardson move
Tue, Nov 24 -
at bizjournals.com | | • | AGN | | AEGON Announces Offering of USD 500 Million of 4.625% Senior Notes
Tue, Nov 24 -
PR Newswire | | • | AGN | | [video] Healthcare Stocks: Safe and Speculative
Mon, Nov 23 -
at TheStreet.com | | • | AGN | | [$$] Banks Flexing Their M&A Muscles
Mon, Nov 23 -
at RealMoney by TheStreet.com | | • | AGN | | UPDATE - Spectrum inks deal with Korea's Handok for cancer drug
Mon, Nov 23 -
at Reuters | | • | ACL | | Wall Street Breakfast: Must-Know News
Mon, Nov 23 -
at Seeking Alpha | | • | ACL | | Kraft weighs higher Cadbury bid as rivals circle: source
Sun, Nov 22 -
Reuters | | • | AGN | | Winners, losers in U.S. Senate health bill
Sat, Nov 21 -
at Reuters | | • | ACL | | [$$] Traders Bet on AMD, Blackstone and Intel
Thu, Nov 19 -
at The Wall Street Journal Online | | • | ACL | | Ventas, Mirant Attract Bears: Options Recap
Mon, Nov 16 -
at TheStreet.com | | | All Headlines for these symbols... |
|
|
|
1.48% Nasdaq 
Competitors
